| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEW |
1 University of Colorado Health Sciences, Department of Medicine, 4200 East Ninth Avenue, Denver, Colorado 80262, USA
2 Veterans Affairs Medical Center, Denver, Colorado 80220, USA
3 Colorado State University, Department of Physiology, Animal Reproduction and Biotechnology Laboratory, Fort Collins, Colorado 80523, USA
(Requests for offprints should be addressed to L M Glode; Email: mike.glode{at}uchsc.edu)
Gonadotropin-releasing hormone (GnRH) is the hypothalamic factor that mediates reproductive competence. Intermittent GnRH secretion from the hypothalamus acts upon its receptor in the anterior pituitary to regulate the production and release of the gonadotropins, LH and FSH. LH and FSH then stimulate sex steroid hormone synthesis and gametogenesis in the gonads to ensure reproductive competence. The pituitary requires pulsatile stimulation by GnRH to synthesize and release the gonadotropins LH and FSH. Clinically, native GnRH is used in a pump delivery system to create an episodic delivery pattern to restore hormonal defects in patients with hypogonadotropic hypogonadism. Agonists of GnRH are delivered in a continuous mode to turn off reproductive function by inhibiting gonadotropin production, thus lowering sex steroid production, resulting in medical castration. They have been used in endocrine disorders such as precocious puberty, endometriosis and leiomyomata, but are also studied extensively in hormone-dependent malignancies. The detection of GnRH and its receptor in other tissues, including the breast, ovary, endometrium, placenta and prostate suggested that GnRH agonists and antagonists may also have direct actions at peripheral targets. This paper reviews the current data concerning differential control of GnRH and GnRH receptor expression and signaling in the hypothalamic–pituitary axis and extrapituitary tissues. Using these data as a backdrop, we then review the literature about the action of GnRH in cancer cells, the utility of GnRH analogs in various malignancies and then update the research in novel therapies targeted to the GnRH receptor in cancer cells to promote anti-proliferative effects and control of tumor burden.
This article has been cited by other articles:
|
|
 |
|
  S. Y. Ko, H. Guo, N. Barengo, and H. Naora Inhibition of Ovarian Cancer Growth by a Tumor-Targeting Peptide That Binds Eukaryotic Translation Initiation Factor 4E Clin. Cancer Res., July 1, 2009; 15(13): 4336 - 4347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tello, S. Wu, J. E. Rivier, and N. M. Sherwood Four functional GnRH receptors in zebrafish: analysis of structure, signaling, synteny and phylogeny Integr. Comp. Biol., November 1, 2008; 48(5): 570 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Blumenfeld and M. von Wolff GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy Hum. Reprod. Update, November 1, 2008; 14(6): 543 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Walters, I. N. Wegorzewska, Y.-P. Chin, M. G. Parikh, and T. J. Wu Luteinizing Hormone-Releasing Hormone I (LHRH-I) and Its Metabolite in Peripheral Tissues Experimental Biology and Medicine, February 1, 2008; 233(2): 123 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Blumenfeld How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries Oncologist, September 1, 2007; 12(9): 1044 - 1054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Singh, A. Krishna, and R. Sridaran Localization of gonadotrophin-releasing hormone I, bradykinin and their receptors in the ovaries of non-mammalian vertebrates Reproduction, May 1, 2007; 133(5): 969 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C Wilson, M S. Salamat, R. J Haasl, K. M Roche, A. Karande, S. V. Meethal, E. Terasawa, R. L Bowen, and C. S Atwood Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression J. Endocrinol., December 1, 2006; 191(3): 651 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morimoto, Y. Osuga, T. Yano, Y. Takemura, M. Harada, T. Hirata, Y. Hirota, O. Yoshino, K. Koga, K. Kugu, et al. GnRH II as a possible cytostatic regulator in the development of endometriosis Hum. Reprod., November 1, 2005; 20(11): 3212 - 3218. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
